alpha-aminopyridine has been researched along with Carcinoma, Neuroendocrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dizdar, L; Forster, CM; Knoefel, WT; Krieg, A; Raba, K; Schott, M; Verde, PE; Werner, TA | 1 |
Coleman, N; Popat, S; Wotherspoon, A; Yousaf, N | 1 |
2 other study(ies) available for alpha-aminopyridine and Carcinoma, Neuroendocrine
Article | Year |
---|---|
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Antigens, CD; Benzylamines; Cadherins; Carcinoma, Neuroendocrine; Cell Cycle; Cell Line, Tumor; Chemokine CXCL12; Child; Cyclams; Epithelial-Mesenchymal Transition; Female; Fibroblast Growth Factor 9; Gene Expression; GPI-Linked Proteins; Heterocyclic Compounds; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Phenotype; Prognosis; Receptors, CXCR; Receptors, CXCR4; Recombinant Proteins; Retrospective Studies; Snail Family Transcription Factors; Survival Rate; Thyroid Neoplasms; Tissue Array Analysis; Tumor Burden; Vimentin; Young Adult | 2017 |
Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib.
Topics: Adult; Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; ErbB Receptors; Gene Rearrangement; Humans; Lactams; Lactams, Macrocyclic; Liver Neoplasms; Lung Neoplasms; Male; Molecular Targeted Therapy; Mutation; Neoplasm Metastasis; Neoplasm Staging; Pyrazoles; Tomography, X-Ray Computed | 2019 |